Regulatory News:
At today’s 93rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the ongoing COVID-19 pandemic and in accordance with Ordinance 3 on measures to combat the coronavirus issued by the Swiss Federal Council, on the basis of Art. 8 of the new COVID-19 Act, shareholders were not permitted to attend the event in person. Shareholders exercised their rights exclusively through the independent proxy and 61.6% of the share capital was represented.
Shareholder approvals
Shareholders approved the Annual Report and the Annual Financial Statements of Vifor Pharma Ltd., as well as the consolidated Financial Statements of Vifor Pharma Group for 2020 by a large majority. The maximum possible 2022 remuneration for the Board of Directors and Executive Committee was also approved, as well as the 2020 Remuneration Report in a consultative vote. In addition, shareholders discharged the member
You have successfully joined our subscriber list.
As Ripple has stated, the surge in sales resulted from the increase in its On-Demand Liquidity (ODL) customers. Besides, it expanded XRP integration within several platforms.
The first three months of 2021 turned out to be highly fortunate for Ripple, the company behind XRP. In the report released on Thursday, Ripple revealed it increased its XRP sales by 97% in the first quarter of 2021, it reached $150.34 million. In comparison, in Q4 2020, this figure was $76.27 million.
Q1 2021 was phenomenally strong for crypto, with the overall market cap ballooning to nearly $2T for the first time.
Check out the latest markets report for insights on the overall market, XRP Ledger development and more. https://t.co/PcgS9DJKWZ
Vifor Pharma Ltd.: 93rd Vifor Pharma Group Annual General Meeting
Election of Dr. Alexandre LeBeaut and Åsa Riisberg as Independent Directors
Dividend of CHF 2.00 approved
Regulatory News:
At today s 93
rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the ongoing COVID-19 pandemic and in accordance with Ordinance 3 on measures to combat the coronavirus issued by the Swiss Federal Council, on the basis of Art. 8 of the new COVID-19 Act, shareholders were not permitted to attend the event in person. Shareholders exercised their rights exclusively through the independent proxy and 61.6% of the share capital was represented.
04.05.2021 New LeBlock from Leclanché Brings the Simplicity of Children s Building Blocks to the Serious Business of Advanced Battery Energy Storage Systems | Leclanché SA | News | Nachricht | Mitteilung
By Sam Kerr
04 May 2021
Swiss-Austrian company Montana Aerospace made a flying start to its IPO on Tuesday, attracting enough investors to cover the transaction in the first few hours of book building.
The company will sell up to 20.95m shares on the SIX Swiss Stock Exchange at a price of Sfr24.15-Sfr25.65 each. The deal could be as large as Sfr506m ($553.7m), including a 15% greenshoe option.The IPO consists solely of primary shares, worth Sfr440m at base deal size. The company
. Already a subscriber? Login